Catálogo de publicaciones - libros

The use of 3D CRT treatment planning and treatment has had a major impact on the practice of radiation therapy. There are very few tumor types whose treatment has not been radically impacted by its use. For the most part this impact has been of major importance and benefit. But as with any major technical advance, the requirements for its use have had a major impact on the requirement for enhanced quality assurance from all members of the treatment team. If one carefully reads the previous sections related to the quality-assurance demands made on the entire treatment team, it is obvious that a great deal more time is required from all involved in the quest to achieve precise and increased dose to the tumor PTV, and to minimize the dose to the normal organs at risk PRV.

Risk for the onset of an alcohol use disorder (AUD) peaks during adolescence and the transition to young adulthood, highlighting the public health significance of alcohol use by adolescents. This chapter summarizes recent research on the diagnosis, course, and assessment of adolescent AUDs. This review focuses on developmental considerations in assessment of AUD criteria, the prevalence of DSM-IV AUDs among adolescents, typical alcohol symptom profiles in youth, and limitations of DSM-IV AUD criteria when applied to adolescents. In addition, studies of AUD course in adolescents, as well as factors influencing the course of AUDs are summarized. The chapter also provides an overview of brief alcohol screening instruments and other measures used in more comprehensive assessment of AUDs in adolescents.

The use of 3D CRT treatment planning and treatment has had a major impact on the practice of radiation therapy. There are very few tumor types whose treatment has not been radically impacted by its use. For the most part this impact has been of major importance and benefit. But as with any major technical advance, the requirements for its use have had a major impact on the requirement for enhanced quality assurance from all members of the treatment team. If one carefully reads the previous sections related to the quality-assurance demands made on the entire treatment team, it is obvious that a great deal more time is required from all involved in the quest to achieve precise and increased dose to the tumor PTV, and to minimize the dose to the normal organs at risk PRV.